20 21 Insulinomas (INS) are the most common neuroendocrine pancreatic tumours in humans and 22 dogs. The long-term prognosis for malignant INS is still poor due to a low success rate of the 23 current treatment modalities, particularly chemotherapy. A better understanding of the 24 molecular processes underlying the development and progression of INS is required to 25 develop novel targeted therapies. Cancer stem cells (CSCs) are thought to be critical for the 26 engraftment and chemoresistance of many tumours, including INS. This study was aimed to 27 characterise and target INS CSCs in order to develop novel targeted therapies. 28 Highly invasive and tumourigenic human and canine INS CSC-like cells were successfully 29 isolated. These cells expressed stem cell markers (OCT4, SOX9, SOX2, CD133 and CD34), 30 exhibited greater resistance to 5-fluorouracil (5-FU), and demonstrated a more invasive and 31 tumourigenic phenotype in vivo compared to bulk INS cells. Here, we demonstrated that 32 Notch-signalling-related genes (NOTCH2 and HES1) were overexpressed in INS CSC-like 33 cells. Protein analysis showed an active NOTCH2-HES1 signalling in INS cell lines, especially 34 in cells resistant to 5-FU. Inhibition of the Notch pathway, using a gamma secretase inhibitor 35 (GSI), enhanced the sensitivity of INS CSC-like cells to 5-FU. When used in combination GSI 36 and 5-FU, the clonogenicity in vitro and the tumourigenicity in vivo of INS CSC-like cells were 37 significantly reduced. These findings suggested that the combined strategy of Notch 38 signalling inhibition and 5-FU synergistically attenuated enriched INS CSC populations, 39 providing a rationale for future therapeutic exploitation. 40 41 42
The embryos were decapitated and the area of the CAM inoculated with the fluorescent cells 180 was harvested and stored in 10% neutral buffered formalin solution (Sigma-Aldrich) and 181 embedded in an agarose block for cutting and staining. The staining was performed with anti-182 cytokeratin (MNF116; Dako) as primary antibody at 1:50 dilution for 30 min followed by 183 staining with secondary antibody Envision anti-Mouse HRP (Dako). Images were taken using 184 a Nikon Eclipse Ni Brightfield Microscope and thereafter processed with Zeiss pro image 185 software (Zeiss). 186
Invasion assay 188
The invasive ability of cells was determined using the QCM™ collagen-based cell invasion 189 assay kit (Millipore, Billerica, MA, USA) according to manufacturer's instructions. Briefly, cells 190 were seeded into the upper inserts at 1 × 10 5 cells per insert in serum-free RPMI. Cells were 191 incubated at 37 °C with 5% CO 2 for 48 hours. Non-invading cells were removed. Cells that 192 migrated through the gel insert to the lower surface were stained and quantified by 193 colorimetric measurement at 560 nm. Images were taken using an Eclipse Ni Brightfield suspension. Plates were incubated at 37 o C with 5% CO 2 until colonies were visible. Growth 229 media were changed once a week. The colonies were fixed by incubating in ice-cold 230 methanol for 5 min at room temperature. Colonies were stained with Giemsa (Invitrogen) 231 according to the manufacturer's instructions. 232 233
Statistical analysis 234
All experiments were repeated at least on two separate occasions. Quantitative analysis was 235 based on a minimum of three replicates. Data were analysed using Minitab® 17 Statistical 236 Software (Minitab Ltd., Coventry, UK) and all graphs and diagrams were generated using 237 were considered statistically significant. When data followed a normal distribution, two 239 sample t-tests were used to compare differences between two samples, or one-sample t-240 tests to determine whether the sample mean was statistically different from a known or 241 hypothesised mean. IC 50 values were calculated using GraphPadPrism 6 (GraphPad 
CSC-like cells are enriched in human and canine INS spheres 248
Human CM adherent cells ( Fig. 1 A) gave rise to small and irregularly shaped spheres ( Fig. 1  249   B ), whereas canine canINS adherent cells ( Fig. 1 C) gave rise to well-rounded large spheres 250 ( Fig. 1 D) . These cells repeatedly formed tumourspheres for up to 15 subsequent passages 251 when plated in low-adherent conditions. To further characterise tumourspheres we examined 252 the expression of embryonic stem cell markers OCT4 and SOX9. Both markers were 253 expressed at a higher level in human ( 
INS CSC-enriched tumourspheres are highly invasive in vitro 266
The invasive capacity of cells was tested in vitro using a collagen-based invasion assay. 267 CSC-like cells displayed a greater invasive potential compared to the non-enriched CSCs 268 ( Fig. 2 A) . When quantified, a statistically significant increased invasive potential was 269 recorded for both human and canine INS CSC-like cells compared with non-enriched CSCs 270 ( Fig. 2 B-C) . 271
INS CSC-enriched tumourspheres are more tumourigenic and invasive in vivo than 273 adherent cells 274
We developed a CAM assay protocol to monitor the tumourigenic and metastatic properties 275 of INS cancer cells. We recorded the amount of fluorescence in triplicate CAMs for both the 276 adherent cells and the CSC-enriched spheres and showed that the adherent INS cells did not 277 form tumours and did not proliferate in the CAM model. However, the CSC-like populations 278 proliferated on the CAM and gave rise to substantial tumours ( Fig. 3 A-B) . We quantified the 279 red fluorescence recorded in the CAM assay and obtained a statistical significant difference 280 for the amount of cells between the canINS adherent and CSC-like cells ( Fig. 3 C) . No 281 statistical difference was recorded between both cell populations of the human INS cell line 282 ( Fig. 3 D) . 283
We then tested whether the cells were able to migrate through the deep layers of the CAM. and its target gene, HES1 were upregulated in both CM and canINS CSC-enriched spheres 303 ( Fig. 1 G) . Using flow cytometry, we provided evidence that the NOTCH2 receptor is 304 constitutively activated as it is present both in its inactive form (extracellular level) and active 305 form (intracellular level) in adherent and CSC-enriched sphere populations ( Fig. 6 A-B) . 306
Using western blot analysis, we showed that both CM and canINS CSC-enriched spheres 307 demonstrated an intrinsic higher expression of NOTCH2 and HES1 compared to the 308 adherent INS cells. Furthermore, treatment of cells with 5-FU resulted in an increased 309 expression of both the inactive and active form of the NOTCH2 receptor in CM (Fig. 6 C) and 310 canINS cells (Fig. 6 D) . In response to an increase in NOTCH2 expression, also its 311 downstream target gene HES1 demonstrated an increased expression in cells that were 312 resistant to 5-FU ( Fig. 6 C-D) . 313 314 enriched spheres ( Fig. 7 A-B) . CSC-enriched canINS spheres demonstrated increased 321 sensitivity to treatment with DAPT compared with CSC-enriched CM spheres. To confirm 322 whether the DAPT is able to specifically inhibit the Notch pathway, we treated the human 323 and canine cells with increasing doses of DAPT and observed, through western blot 324 analysis, a reduced expression of the intracellular form of NOTCH2 (NOTCH2-IC) and its 325 downstream target HES1 in both human and canine INS cell lines (Fig. 7 C-D) . We 326 demonstrated that a blockade of the Notch signalling occurs in CSC-enriched canINS 327 spheres at a lower dose of DAPT compared to CSC-enriched CM spheres ( Fig. 7 C-D) . 
Inhibition of Notch signalling decreases viability and 5-FU resistance in INS CSC-

Notch inhibition enhances chemosensitivity to 5-FU treatment of INS CSC-enriched 335 tumourspheres in vivo 336
In order to validate the results obtained in vitro, we tested this approach in the in vivo CAM 337 model. Treatment with either 5-FU, DAPT, or their combination, in the CAM model 338 demonstrated that the human and canine INS CSC populations were not able to proliferate 339 when treated with a combination of 5-FU and DAPT ( Fig. 8 A-B) . We recorded the amount of 340 fluorescence in the triplicate CAMs for the different conditions and demonstrated that the 341 combination of 5-FU and DAPT significantly decreased the proliferation of INS CSC-like cells, 342 while neither treatment with DAPT, or 5-FU alone led to a significant reduction in cell 343 proliferation ( Fig. 8 C-D) . 
